The mission

is to develop superior second generation vaccines and efficient non-invasive administration systems, based on the company’s technology platforms.

 

The vision

is to become an internationally recognized leader in the development of vaccines and systems for non invasive delivery systems.

The strategy

is to develop the company through strategic partnerships, licensing, and continued consolidation of proprietary platform technologies and intellectual property.

The company is located at Symbion Science Park in Copenhagen, Denmark. This region is designated Medicon Valley and is one of Europe’s major centers for biotechnology and life science R&D.

In addition to offices and a GLP qualified laboratory facility at Symbion, the company has access to nearby laboratory facilities at the State hospital and animal facilities at the neighboring Panum Institute.

Currently, Nordic vaccine holds a staff of 6 highly skilled employees, working primarily with vaccine development. This is supplemented by resources from a co-development partner and Ph.D. students.

All administrative functions including economy, IT, as well as regulatory and clinical support are extensively outsourced, in order to reduce expenditures and investments.  

 More.....